We then addressed the question if solely selective overexpression of PPARβ/δ in endothelial cells would be sufficient to enhance tumor angiogenesis and growth independently of the status of PPARβ/δ expression in cancer and non-endothelial host cells. This evidence concerns the gene PPARD and neoplasm.